Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Anthera Pharmaceuticals Inc. (ANTH)

0.065 0 (0%)

11-15 12:51

Open:

0.065

Pre. Close:

0.065

High:

0.065

Low:

0.065

Volume:

8,361

Market Cap:

2M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.06 - 0.06

0.06 - 0.061

Low:

0.059 - 0.06

0.06 - 0.06

Close:

0.059 - 0.06

0.06 - 0.061

Technical analysis  (as of: 2018-11-15 12:42:51 PM)

Overall:

      

Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 0.09     One year: 0.11

Support:

Support1: 0.04    Support2: 0.01

Resistance:

Resistance1: 0.08    Resistance2: 0.09

Pivot:

0.07

Moving Averages:

MA(5): 0.07     MA(20): 0.07

MA(100): 0.08     MA(250): 0.66

MACD:

MACD(12,26):     Signal(12,26,9):

%K %D:

%K(14,3): 80.00     %D(3): 82.38

RSI:

RSI(14): 42.97

52-Week:

High: 2.97  Low: 0.01  Change(%): -97.1

Average Vol(K):

3-Month: 7742  10-Days 3280

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ANTH has closed above bottom band by 30.9%. Bollinger Bands are 70.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to ANTH's normal range. The bands have been in this narrow range for 160 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-06-27T09:10:13-04:00
Anthera Pharma to be delisted tomorrow; shares down 33.5%

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

26.18

Shares Float (M)

25.35

% Held by Insiders

% Held by Institutions

35.20

Shares Short (K)

2015

Shares Short Prior Month (K)

Stock Financials

EPS

-2.590

EPS Est. Current Year

-3.680

EPS Est. Next Year

-3.100

EPS Est. Next Quarter

-0.950

Forward EPS

-1.761

Book Value (p.s.)

1.300

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-138.1

Return on Equity (ttm)

-606.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.625

Qtrly Earnings Growth

Operating Cash Flow (M)

-31.95

Levered Free Cash Flow (M)

-17.92

Valuation

P/E

-0.03

P/E Growth Ratio

P/BV

0.05

P/S

P/CF

-0.05

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-05-01

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.